Litcius/Paper detail

Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co‐morbidities

Dipankar De, Akanksha Kaushik, Sabia Handa, Rahul Mahajan, Enno Schmidt

2021Journal of the European Academy of Dermatology and Venereology20 citationsDOI

Topics & Concepts

VenereologyMedicineDermatologyOmalizumabFamily medicineImmunoglobulin EAntibodyImmunologyAutoimmune Bullous Skin DiseasesUrticaria and Related ConditionsCoagulation, Bradykinin, Polyphosphates, and Angioedema
Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co‐morbidities | Litcius